OUR BUSINESS AT A GLANCE
Development of Business.
The Company was incorporated under the Laws of England and Wales in June 2010. Effective October, 12, 2012, the year where the Company succeeded, as a reporting company of the initial Pharmaceutical and Biotechnology Division of her matrix Company, the predecessor of ND Pharma & Biotech Co. Ltd. The Company's Registered Address are located at the beautiful southeast of England at Surrey specifically 11 Church Street, Great Bookham, Leatherhead, Surrey, England, in the United Kingdom. The Company maintain executive offices in southeast Europe, (Spain), Luxembourg, United States, Latin America and other countries. The Company is establishing a solid ground network of agents, distributors and sales force as well as operating plants and manufacturing contract in a number of countries worldwide, mainly The European Union and The United States.
Description of Business
The Company is intending to be a leading Life Science and High Technology company. The Company develops, manufactures, purchases and distributes one of the broadest range of high quality chemicals, biochemicals, brand products and industry solutions as well as certain equipment available throughout the world and also provides global biopharmaceutical services including research and development of pharmaceutical, biopharmaceutical, biotechnology, medical, healthcare, agriculture and veterinary products. These products, kits and services are used in scientific research, including genomic and proteomic research, biotechnology, pharmaceutical development and as key components in pharmaceutical, diagnostic and other high technology manufacturing. The Company operates in a number of countries, with a plant and storage manufacturing approximately 68,000 of the 170,000 chemical and biochemical products it offers. The Company sells worldwide both directly and through a net of commercial entities and other agents and distributors schemes having an ever-growing portfolio of customers and clients spread into approximately 160 countries servicing products.
Products and Services
The Company provides products and services that focus on:
• research customers that use smaller quantities of our products in basic life science and high-technology R&D;
• manufacturing customers that use our products in larger quantities in lab-stage development and manufacturing;
• life science customers who use our biopharmaceutical products and services to facilitate the development, manufacturing and commercialization of biological and chemical drugs; and
• industrial and diagnostic companies that use our products in various forms of assays and testing as well as in clinical diagnostics.
The 3 main areas of business are:
Research provides reagents and consumables to life sciences and non-profit research organizations.
Applied provides raw materials and solutions for testing in clinical and industrial applications.
Commercial provides manufacturing raw materials for commercial products throughout its own divisions.
Sales and Distribution
Since 2012, the initial full year of operations, The Company sold products and services to a number of accounts representing an increasing number of individual customers, including pharmaceutical companies, universities, commercial laboratories, industrial companies (food and beverages, veterinary, feed, agriculture, fisheries, crop and crop protection and development), biotechnology companies, non-profit organizations, governmental institutions, diagnostic, chemical and electronics companies and hospitals. Orders vary from one to another since the small orders in laboratory materials to the large-scale bulk orders to certain industrial sectors including food, health, nutrition, consumer brands, personal care, and others. The Company also makes its chemical products available in larger-scale quantities for use in manufacturing.
As many other highly capitalized private companies ND Pharma & Biotech trading activities are developed thru a network of agents, distributors, subsidiaries, affiliates, etc. ND Pharma IS NOT A TRADING COMPANY and therefore DOES NOT sell directly to any third parties unless distribution agreements, supply contracts and licenses that may be authorized and/or issued by The Company or it´s official representatives on our behalf. Any offer, invitation to treat, pre-agreement, agreement, contract, license, or any other instrument of negotiation, etc, shall be construed over express and written license and/or permission from ND Pharma & Biotech priorly and as a preceptive pre-requisite, otherwise any form of negotiation construed in absence of such requirement will be invalid and claim for damages will be enforced under applicable laws in any territory and/or jurisdiction enforceable and/or where operations were established.
Customers and potential customers, wherever located, are encouraged to contact the Company by telephone or via its websites (www.ndpharmabiotech.com) and from this to other website, product-sites and micro-site available to make enquiries and eventually to place orders or obtain technical staff consultation. Alternatively company can be contacted directly through the different contact forms and writing an e-mail to the address: [email protected], referencing the issue and/or product or service of interest. A commercial agent and/or a representative will contact you immediately. Shipments are made at least five days per week from all locations conducting manufacturing and/or distribution activities. The established system is quite simple and effective. Customers ask for quotation of products and services, quotes should be issued and accepted in accordance with our general sales conditions. Once payment is confirmed by our financial department, The Company strives to ship its products to customers on the same day a payment order is received and carries inventory levels which it believes to be appropriate to maintain/sustain this practice.
The Company was incorporated under the Laws of England and Wales in June 2010. Effective October, 12, 2012, the year where the Company succeeded, as a reporting company of the initial Pharmaceutical and Biotechnology Division of her matrix Company, the predecessor of ND Pharma & Biotech Co. Ltd. The Company's Registered Address are located at the beautiful southeast of England at Surrey specifically 11 Church Street, Great Bookham, Leatherhead, Surrey, England, in the United Kingdom. The Company maintain executive offices in southeast Europe, (Spain), Luxembourg, United States, Latin America and other countries. The Company is establishing a solid ground network of agents, distributors and sales force as well as operating plants and manufacturing contract in a number of countries worldwide, mainly The European Union and The United States.
Description of Business
The Company is intending to be a leading Life Science and High Technology company. The Company develops, manufactures, purchases and distributes one of the broadest range of high quality chemicals, biochemicals, brand products and industry solutions as well as certain equipment available throughout the world and also provides global biopharmaceutical services including research and development of pharmaceutical, biopharmaceutical, biotechnology, medical, healthcare, agriculture and veterinary products. These products, kits and services are used in scientific research, including genomic and proteomic research, biotechnology, pharmaceutical development and as key components in pharmaceutical, diagnostic and other high technology manufacturing. The Company operates in a number of countries, with a plant and storage manufacturing approximately 68,000 of the 170,000 chemical and biochemical products it offers. The Company sells worldwide both directly and through a net of commercial entities and other agents and distributors schemes having an ever-growing portfolio of customers and clients spread into approximately 160 countries servicing products.
Products and Services
The Company provides products and services that focus on:
• research customers that use smaller quantities of our products in basic life science and high-technology R&D;
• manufacturing customers that use our products in larger quantities in lab-stage development and manufacturing;
• life science customers who use our biopharmaceutical products and services to facilitate the development, manufacturing and commercialization of biological and chemical drugs; and
• industrial and diagnostic companies that use our products in various forms of assays and testing as well as in clinical diagnostics.
The 3 main areas of business are:
Research provides reagents and consumables to life sciences and non-profit research organizations.
Applied provides raw materials and solutions for testing in clinical and industrial applications.
Commercial provides manufacturing raw materials for commercial products throughout its own divisions.
Sales and Distribution
Since 2012, the initial full year of operations, The Company sold products and services to a number of accounts representing an increasing number of individual customers, including pharmaceutical companies, universities, commercial laboratories, industrial companies (food and beverages, veterinary, feed, agriculture, fisheries, crop and crop protection and development), biotechnology companies, non-profit organizations, governmental institutions, diagnostic, chemical and electronics companies and hospitals. Orders vary from one to another since the small orders in laboratory materials to the large-scale bulk orders to certain industrial sectors including food, health, nutrition, consumer brands, personal care, and others. The Company also makes its chemical products available in larger-scale quantities for use in manufacturing.
As many other highly capitalized private companies ND Pharma & Biotech trading activities are developed thru a network of agents, distributors, subsidiaries, affiliates, etc. ND Pharma IS NOT A TRADING COMPANY and therefore DOES NOT sell directly to any third parties unless distribution agreements, supply contracts and licenses that may be authorized and/or issued by The Company or it´s official representatives on our behalf. Any offer, invitation to treat, pre-agreement, agreement, contract, license, or any other instrument of negotiation, etc, shall be construed over express and written license and/or permission from ND Pharma & Biotech priorly and as a preceptive pre-requisite, otherwise any form of negotiation construed in absence of such requirement will be invalid and claim for damages will be enforced under applicable laws in any territory and/or jurisdiction enforceable and/or where operations were established.
Customers and potential customers, wherever located, are encouraged to contact the Company by telephone or via its websites (www.ndpharmabiotech.com) and from this to other website, product-sites and micro-site available to make enquiries and eventually to place orders or obtain technical staff consultation. Alternatively company can be contacted directly through the different contact forms and writing an e-mail to the address: [email protected], referencing the issue and/or product or service of interest. A commercial agent and/or a representative will contact you immediately. Shipments are made at least five days per week from all locations conducting manufacturing and/or distribution activities. The established system is quite simple and effective. Customers ask for quotation of products and services, quotes should be issued and accepted in accordance with our general sales conditions. Once payment is confirmed by our financial department, The Company strives to ship its products to customers on the same day a payment order is received and carries inventory levels which it believes to be appropriate to maintain/sustain this practice.
Unique Business Model for Unparalleled Results
Patents, Trademarks, Industrial Secrets, Licenses and other IP Rights
The Company holds approximately 750 IP right-protected elements from patent, patent applications, industrial secrets, marks, trademarks and trademark applications, and other IP Rights generator issues from a total documentary repository of +5 Million documents. company holds a number of significant trademarks in different fields and sectors from Food & Nutrition to Medical and Healthcare or Pharmaceutical fields. These trademarks are increasing and we developed an actual portfolio of development valued over +750 M€ by creditor agencies and expert research valuation companies, banks and other authorized operating agents.
The Company is aware of the desirability for patent and trademark protection for its products. The Company believes that other than its brand names, no single patent, license or trademark (or related group of patents, licenses or trademarks) is material in relation to its business as a whole. In addition to patents and other existing IP rights, the Company relies on trade secrets and proprietary know-how. The Company seeks protection of these trade secrets and proprietary know-how, in part, through confidentiality and proprietary information agreements. The Company makes efforts to require its employees, directors, consultants and advisors, outside scientific collaborators and sponsored researchers, other advisors and other individuals and entities to execute confidentiality agreements upon the start of employment, consulting or other contractual relationships with the Company. These agreements provide that all confidential information developed or made known to the individual or entity during the course of the relationship is to be kept confidential and not disclosed to third parties except in specific circumstances. In the case of employees and some other parties, the agreements provide that all inventions conceived by the individual will be the Company's exclusive property. These agreements may not provide meaningful protection for or adequate remedies to protect the Company's technology in the event of unauthorized use or disclosure of information. Furthermore, the Company's trade secrets may otherwise become known to, or be independently developed by, its competitors. Despite this, our Legal and Regulatory department are highly aware of any infringement of such rights pertaining to The Company to execute our legal rights and remedies to its total extent.
Competition
The markets for the Company's products, services and technologies are both competitive and price sensitive. The Company believes it is a major supplier of biochemical and organic chemical products used in scientific research and testing laboratories, including industrial applications, genomics and proteomics research, biotechnology, pharmaceutical development and as key components in pharmaceutical, diagnostic, environmental and other high technology manufacturing. The Company offers approximately 210,800 chemical, biologic and equipment items, some of which are unique with limited demand including some rare and ultra-rare molecules, active principles and other. There are many competitors that offer a narrower range of chemicals and many others offering a broad range of equipment products.
In all product areas, the Company competes primarily on the basis of customer service, product availability, quality and price. The Company's main marketing vehicles include its websites starting from the main one www.ndpharmabiotech.com and all derived as well as catalogs both electronically and alternatively printed (The Company maintains a sustainable policy of "paper-free" business), and other marketing materials designed and made on behalf of our existing brands and future developments. These catalogs may be supplemented with advertisements in life science, chemical and other scientific journals and trade publications, the mailing and e-mailing of special product brochures, the electronic distribution of various advertisements and product data, social media, news releases related to new product offerings and through personal visits with customers from management, sales and technical representatives.
